ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2025; 50(2): 496-500


Effects of simvastatin and aqueous extract of seeds of ajwa dates on Non-Alcoholic Fatty Liver Disease in a rat model of dyslipidemia

Farooq Sultan, Tehreem Zulfiqar, Bisma Fatima Aslam, Sadia Maqsood, Saadia Shahzad Alam, Mudassara Saqib.



Abstract
Download PDF Post

Objective: To assess the histological effects of simvastatin and Ajwa date seed extract on non-alcoholic fatty liver disease (NAFLD).
Methodology: It is an in-vitro experimental animal study, 5 groups of eight rats each were created. Group 1 was a healthy control group. In Group, 2 animals were fed with butter for 36 days and left untreated. Group 3 and 4 were treated with simvastatin 10mg/kg/day and Aqueous extract of Seeds of Ajwa date (ADSE) 8ml/kg/day, respectively. Group 5 received simvastatin and ADSE together in half recommended doses that is 5mg/kg/day and 4ml/kg/day, respectively. Hyperlipidaemia was induced in 15 days and treatment with simvastatin and ADSE continued for 21 days making it 36 days study. Then animals were sacrificed, liver samples were eosin haematoxylin stained. The histopathological characteristics were statistically analysed using Fisher's exact test.
Results: Simvastatin & ADSE when used individually and together showed considerable hepatoprotective effects against NAFLD. However, the group that received half dose combination showed fewer promising effects.
Conclusion: Ajwa date seed may have therapeutic potential in NAFLD.

Key words: Hyperlipidemia, ajwa date seed, simvastatin.





Bibliomed Article Statistics

40
48
22
17
16
19
14
16
17
2
R
E
A
D
S

47

172

46

18

12

18

17

12

26

3
D
O
W
N
L
O
A
D
S
05060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.